ADAPY
Adaptimmune Therapeutics PLC · NASDAQ NMS - GLOBAL MARKET · Biotechnology
$0.01$-0.01 (-25.00%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for ADAPY is being prepared.
Key Stats
Key Stats
Open
$0.01
Day High
$0.01
Day Low
$0.01
Prev Close
$0.02
Volume
0
Avg Volume
227.9K
Day Change
$-0.01
Change %
-25.00%
Fundamentals
Fundamentals
P/B
11.63
EPS (TTM)
$-0.11
Market Cap
$5M
52-Wk Range
$0.00 — $0.36
Earnings History
Insider Activity
Who Owns This Stock
Who Owns ADAPY
Other99.8%9 holders
Based on Q4 2025 13F filings + AC behavioral model
11 institutional holders
Top Holders
0.0%$20.8B
$11.3B
$11.3B
$9.2B
+49.8%$483M
-36.3%$95M
0.0%$66M
0.0%$23M
-98.8%$0K
-99.8%$0K
0.0%$0K
-2.0%$0K
0.0%$0K
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Mild Selling Pressure
Other(99.8%)
●
—Passive / Index(0.2%)
●
HoldsDealer / Bank(0.0%)
●
Facilitating0% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↓Analyst Consensus0 buy, 2 hold, 4 sellFinnhub
→Inst. Flows5 increased/new, 4 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of ADAPY on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.
